VIM
AUPH icon

Vinva Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Vinva Investment Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$325K Buy
+15,958
New +$233K ﹤0.01% 416

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vinva Investment Management's AUPH Position: Q1 2026 in Review

Vinva Investment Management opened a new position in Aurinia Pharmaceuticals (AUPH) in Q1 2026: 15,958 shares worth $325K. The stake represents ﹤0.01% of the portfolio and ranks #416 among its holdings.

259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Vinva Investment Management held 15,958 shares of Aurinia Pharmaceuticals worth $325K as of Q1 2026.
  • Aurinia Pharmaceuticals was a new Vinva Investment Management position in Q1 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Vinva Investment Management's portfolio in Q1 2026, its #416 holding.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.